Head of Yemen Reconciliation Commission to Asharq Al-Awsat: We Are Keen on Peace, Stability

Head of the Consultations and Reconciliation Commission Mohammed al-Ghaithi.
Head of the Consultations and Reconciliation Commission Mohammed al-Ghaithi.
TT

Head of Yemen Reconciliation Commission to Asharq Al-Awsat: We Are Keen on Peace, Stability

Head of the Consultations and Reconciliation Commission Mohammed al-Ghaithi.
Head of the Consultations and Reconciliation Commission Mohammed al-Ghaithi.

Head of the Consultations and Reconciliation Commission of the Yemen Presidential Leadership Council (PLC), Mohammed al-Ghaithi revealed that the body will work on preserving the unity of all forces and political powers.

In his first remarks to the media since his appointment, he told Asharq Al-Awsat that the PLC will rely on the commission in carrying out its duties and tasks.

The PLC is keen on the participation of all sides in consultations and decision-making.

The people are hoping for real change, summed up by the liberation of the North and stability in southern provinces, binging an end to Iran's agenda in Yemen and protecting the security and peace of the region and its future, he stressed.

Moreover, he noted that even though the Iran-backed Houthi militias receive their orders from Tehran, the PLC is seeking real peace.

Ghaithi warned that if the militias choose to return to war, then they will be faced with a conflict unlike what they have seen before.

The current stage demanded that all anti-Houthi forces stand united, meaning the commission must maintain the stances of the joint forces and political groups that make them up.

This is very important, he stressed, especially since "we have shared goals in achieving peace and confronting Houthi intransigence. No one can dispute this. We all need the cooperation of all forces to stabilize the economy and achieve internal security, unite media political discourse and effectively activate state institutions."

He explained that the members and chairman of the PLC were chosen through consensus, which "gives us hope that consensus would mark this very critical phase in Yemen."

"Even though I am a member of the Southern Transitional Council (STC), which I am very proud of, today I am representing the expectations and views of all parties," he stated.

"I will be keen on consensus and rapprochement at all times," he told Asharq Al-Awsat.

Furthermore, Ghaithi said consensus does not eliminate various security, political, economic and social priorities.

For example, he explained that the case of the people of the South does not contradict the need to stand united in confronting the Houthis or reforming the economy. The southerners will determine their political future through their own will and this applies to all other parties.

The PLC is keen on the participation of all sides in the consultations and decision-making, he added. "This is an extraordinary phase and I am very optimistic."

The people have high expectations from the PLC and "we are responsible before God and history," he remarked. "The changes must be collectively introduce."

"I am speaking here of real change that can be felt by the people. This includes the liberation of the northern provinces, defeating Iran, protecting the security and future of the region and respecting the will of the people, without exception, in the South and the North," stated Ghaithi.

Turning to Saudi Arabia, he described Riyadh as a "peacemaker". The Yemeni people flocked to Riyadh for the consultations earlier this month and they returned from it united.

As a member of the STC, he stressed that "we are always keen on success and supporting the efforts of our brothers in Saudi Arabia. This is a firm principle in our policy and stances," he added.

"The Riyadh consultations have met our previous demands and it indeed reformed the presidency, tackled the economy and granted us real partnership in decision-making," he stated. "It confirmed the need for the South to decide its fate."

"Peace is our only option and the only option of our brothers in the region," he continued.

"If the Houthis decide to go back to their stalling and intransigence and reject peace, if they choose war, then the conflict will differ from its predecessors and the militias will pay a heavy price for such irrational actions," he warned.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.